Ajax-Loading

Novartis AG - Total Stockholder Equity

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Stockholder-Equity" stands at 44.75 Billion United States Dollars as of 09/30/2025, the highest value since 03/31/2024.

As of the end of Novartis AG's third quarter, the item "Total Stockholder Equity" stands at 44.75 Billion USD. This represents an increase of 6.42 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.02 percent compared to the value the year prior.
The 1 year change in percent is 3.02.
The 3 year change in percent is -26.51.
The 5 year change in percent is -17.97.
The 10 year change in percent is -41.72.

The Serie's long term average value is 62.31 Billion United States Dollars. It's latest available value, on 09/30/2025, is 28.18 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +17.01%.
The Serie's change in percent from it's maximum value, on 06/30/2015, to it's latest available value, on 09/30/2025, is -43.23%.

Total Stockholder Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Stockholder Equity905,699,262,464.00
LogoJohnson & Johnson - Total Stockholder Equity486,508,953,600.00
LogoAbbVie Inc - Total Stockholder Equity399,570,305,024.00
LogoRoche Holding AG - Total Stockholder Equity317,433,206,677.55
LogoAstraZeneca PLC - Total Stockholder Equity280,205,508,085.11